Pervasive and opposing effects of Unpredictable Chronic Mild Stress (UCMS) on hippocampal gene expression in BALB/cJ and C57BL/6J mouse strains

BMC Genomics

Volumn 16, Issue 1, 2015, Pages

  Malki, Karim ^a   Mineur, Yann S ^b,g   Tosto, Maria Grazia ^a,e   Campbell, James ^c   Karia, Priya ^a   Jumabhoy, Irfan ^a   Sluyter, Frans ^a   Crusio, Wim E ^d,g   Schalkwyk, Leonard C ^f  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e TOMSK STATE UNIVERSITY   (Russian Federation)

^f UNIVERSITY OF ESSEX   (United Kingdom)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

BALB cJ; C57BL 6J; Stress; Ubc; UCMS; Unpredictable chronic mild stress

Indexed keywords

MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CHRONIC STRESS; CONTROLLED STUDY; CPNE1 GENE; CREB1 GENE; CREM GENE; DEPRESSION; FABP7 GENE; FEMALE; FYN GENE; GENE; GENE EXPRESSION; GRIK1 GENE; HIPPOCAMPUS; HNRPDL GENE; HOMER1 GENE; HTR1A GENE; IL1B GENE; IMMUNE RESPONSE; INFLAMMATION; MALE; MATERNAL DEPRIVATION; MOUSE; NCAM1 GENE; NFKB1 GENE; NONHUMAN; NPY GENE; PTPRA GENE; STRAIN DIFFERENCE; TST GENE; UBC GENE; UNPREDICTABLE CHRONIC MILD STRESS; VLDLR GENE; ZW10 GENE; ANIMAL; BRAIN; C57BL MOUSE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MAJOR DEPRESSION; MENTAL STRESS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROTEIN SYNTHESIS; SPECIES DIFFERENCE;

ANIMALIA; MUS;

ANIMALS; BRAIN; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROTEIN BIOSYNTHESIS; SPECIES SPECIFICITY; STRESS, PSYCHOLOGICAL;

EID: 84928535869     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/s12864-015-1431-6     Document Type: Article

References (78)

1. Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry. 2005; 58:175-89.
2. Fava M, Kendler KS. Major depressive disorder. Neuron. 2000; 28:335-41.
3. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of dsm-iv disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005; 62:593-602.
4. Nestler EJ, Hyman SE. Animal models of neuropsychiatric disorders. Nat Neurosci. 2010; 13:1161-9.
5. Kessler RC. The effects of stressful life events on depression. Annu Rev Psychol. 1997; 48:191-242.
6. de Kloet ER, Sibug RM, Helmerhorst FM, Schmidt MV. Stress, genes and the mechanism of programming the brain for later life. Neurosci Biobehav Rev. 2005; 29:271-81.
7. Meaney MJ. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu Rev Neurosci. 2001; 24:1161-92.
8. Graham YP, Heim C, Goodman SH, Miller AH, Nemeroff CB. The effects of neonatal stress on brain development: implications for psychopathology. Dev Psychopathol. 1999; 11:545-65.
9. Heim C, Nemeroff CB. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry. 2001; 49:1023-39.
10. Katz RJ. Animal models and human depressive disorders. Neurosci Biobehav Rev. 1981; 5:231-46.
11. Willner P, Muscat R, Papp M. An animal model of anhedonia. Clin Neuropharmacol. 1992; 15(Suppl 1 Pt A):550-1.
12. Willner P, Muscat R, Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev. 1992; 16:525-34.
13. Mitchell PJ, Redfern PH. Animal models of depressive illness: the importance of chronic drug treatment. Curr Pharm Des. 2005; 11:171-203.
14. Willner P. Chronic mild stress (cms) revisited: consistency and behavioural-neurobiological concordance in the effects of cms. Neuropsychobiology. 2005; 52:90-110.
15. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl). 1997; 134(4):319-29.
16. Pothion S, Bizot JC, Trovero F, Belzung C. Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress. Behav Brain Res. 2004; 155:135-46.
17. Mineur YS, Prasol DJ, Belzung C, Crusio WE. Agonistic behavior and unpredictable chronic mild stress in mice. Behav Genet. 2003; 33(5):513-9.
18. Mineur YS, Belzung C, Crusio WE. Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice. Behav Brain Res. 2006; 175(1):43-50.
19. Mineur YS, Belzung C, Crusio WE. Functional implications of decreases in neurogenesis following chronic mild stress in mice. Neuroscience. 2007; 150(2):251-9.
20. Belzung C, Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res. 2001; 125(1-2):141-9.
21. Dulawa SC, Holick KA, Gundersen B, Hen R. Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology. 2004; 29:1321-30.
22. Tang X, Orchard SM, Sanford LD. Home cage activity and behavioral performance in inbred and hybrid mice. Behav Brain Res. 2002; 136:555-69.
23. Bouwknecht JA, Paylor R. Behavioral and physiological mouse assays for anxiety: a survey in nine mouse strains. Behav Brain Res. 2002; 136:489-501.
24. Robertson HA. Benzodiazepine receptors in "emotional" and "non-emotional" mice; comparison of four strains. Eur J Pharmacol. 1979; 56:163-6.
25. Velez L, Sokoloff G, Miczek KA, Palmer AA, Dulawa SC. Differences in aggressive behavior and dna copy number variants between balb/cj and balb/cbyj substrains. Behav Genet. 2010; 40(2):201-10.
26. Kim S, Lee S, Ryu S, Suk J, Park C. Comparative analysis of the anxiety-related behaviors in four inbred mice. Behav Processes. 2002; 60:181-190.
27. Tarantino LM, Sullivan PF, Meltzer-Brody S. Using animal models to disentangle the role of genetic, epigenetic, and environmental influences on behavioral outcomes associated with maternal anxiety and depression. Front Psychiatry. 2011; 2:44.
28. Anisman H, Zaharia MD, Meaney MJ, Merali Z. Do early-life events permanently alter behavioral and hormonal responses to stressors?Int J Dev Neurosci. 1998; 16:149-64.
29. Yilmazer-Hanke DM, Roskoden T, Zilles K, Schwegler H. Anxiety-related behavior and densities of glutamate, gabaa, acetylcholine and serotonin receptors in the amygdala of seven inbred mouse strains. Behav Brain Res. 2003; 145(1-2):145-59.
30. Sugimoto Y, Kajiwara Y, Hirano K, Yamada S, Tagawa N, Kobayashi Y, et al.Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding. Eur J Pharmacol. 2008; 592:116-22.
31. Lucki I, Dalvi A, Mayorga AJ. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl). 2001; 155:315-22.
32. Alcaro A, Cabib S, Ventura R, Puglisi-Allegra S. Genotype- and experience-dependent susceptibility to depressive-like responses in the forced-swimming test. Psychopharmacology (Berl). 2002; 164:138-43.
33. Pinhas A, Aviel M, Koen M, Gurgov S, Acosta V, Israel M, et al.Strain differences in sucrose- and fructose-conditioned flavor preferences in mice. Physiol Behav. 2012; 105:451-9.
34. Jiao J, Nitzke AM, Doukas DG, Seiglie MP, Dulawa SC. Antidepressant response to chronic citalopram treatment in eight inbred mouse strains. Psychopharmacology (Berl). 2011; 213:509-20.
35. Fernandes C, Paya-Cano JL, Sluyter F, D'Souza U, Plomin R, Schalkwyk LC. Hippocampal gene expression profiling across eight mouse inbred strains: towards understanding the molecular basis for behaviour. Eur J Neurosci. 2004; 19:2576-82.
36. Mineur YS, Obayemi A, Wigestrand MB, Fote GM, Calarco CA, Li AM, et al.Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior. Proc Natl Acad Sci U S A. 2013; 110(9):3573-8.
37. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al.Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science. 2003; 301(5634):805-9.
38. Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci. 1999; 19:5034-43.
39. Malki K, Lourdusamy A, Binder E, Paya-Cano J, Sluyter F, Craig I, et al.Antidepressant-dependent mrna changes in mouse associated with hippocampal neurogenesis in a mouse model of depression. Pharmacogenet Genomics. 2012; 22:765-76.
40. Malki K, Uher R, Paya-Cano J, Binder E, Rietschel M, Zobel A, et al.Convergent animal and human evidence suggests a role of ppm1a gene in response to antidepressants. Biol Psychiatry. 2011; 69(4):360-5.
41. Binder E, Malki K, Paya-Cano JL, Fernandes C, Aitchison KJ, Mathe AA, et al.Antidepressants and the resilience to early-life stress in inbred mouse strains. Pharmacogenet Genomics. 2011; 21:779-89.
42. Malki K, Tosto MG, Jumabhoy I, Lourdusamy A, Sluyter F, Craig I, et al.Integrative mouse and human mrna studies using wgcna nominates novel candidate genes involved in the pathogenesis of major depressive disorder. Pharmacogenomics. 2013; 14(16):1979-90. doi:10.2217/pgs.13.154.
43. Malki K, Campbell J, Davies M, Keers R, Uher R, Ward M, et al.Pharmacoproteomic investigation into antidepressant response in twos mouse inbred strains. Proteomics. 2012; 12(14):2355-65.
44. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al.Influence of life stress on depression: moderation by a polymorphism in the 5-htt gene. Science. 2003; 301(5631):386-9.
45. Malki K, Keers R, Tosto MG, Lourdusamy A, Carboni L, Domenici E, et al.The endogenous and reactive depression subtypes revisited: integrative animal and human studies implicate multiple distinct molecular mechanisms underlying major depressive disorder. BMC Med. 2014; 12:73. doi:10.1186/1741-7015-12-73.
46. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al.Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003; 4(2):249-64. doi:10.1093/biostatistics/4.2.249.
47. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A. 2001; 98(1):31-6. doi:10.1073/pnas.011404098.
48. van den Berg RA, Hoefsloot HCJ, Westerhuis JA, Smilde AK, van der Werf MJ. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics. 2006; 7:142. doi:10.1186/1471-2164-7-142.
49. Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005; 4:17. doi:10.2202/1544-6115.1128.
50. Dong J, Horvath S. Understanding network concepts in modules. BMC Syst Biol. 2007; 1:24.
51. Langfelder P, Zhang B, Horvath S. Defining clusters from a hierarchical cluster tree: the dynamic tree cut package for r. Bioinformatics. 2008; 24(5):719-20. doi:10.1093/bioinformatics/btm563.
52. Malki K, Pain O, Tosto MG, Du Rietz E, Carboni L, Schalkwyk LC. Identification of genes and gene pathways associated with major depressive disorder by integrative brain analysis of rat and human prefrontal cortex transcriptomes. Transl Psychiatry. 2015:5:e519. http://dx.doi.org/10.1038/tp.2015.15 doi:10.1038/tp.2015.15.
53. Miller JA, Cai C, Langfelder P, Geschwind DH, Kurian SM, Salomon DR, et al.Strategies for aggregating gene expression data: the collapserows r function. BMC Bioinformatics. 2011; 12:322. doi:10.1186/1471-2105-12-322.
54. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron. 2002; 34(1):13-25.
55. Miller JA, Horvath S, Geschwind DH. Divergence of human and mouse brain transcriptome highlights alzheimer disease pathways. Proc Natl Acad Sci U S A. 2010; 107(28):12698-703. doi:10.1073/pnas.0914257107.
56. Belzung C, Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res. 2001; 125(1-2):141-9.
57. Dulawa SC, Holick KA, Gundersen B, Hen R. Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology. 2004; 29(7):1321-30.
58. Marona-Lewicka D, Vetulani J. Neurochemical correlates of differences in responses to psychotropic drugs. i. apomorphine and morphine effects on locomotor activity of c57/bl and balb/c mice. Pol J Pharmacol Pharm. 1989; 41(5):431-8.
59. Tang X, Orchard SM, Sanford LD. Home cage activity and behavioral performance in inbred and hybrid mice. Behav Brain Res. 2002; 136(2):555-69.
60. Zhang X, Beaulieu J-M, Sotnikova TD, Gainetdinov RR, Caron MG. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science. 2004; 305(5681):217.
61. Lawrence T. The nuclear factor nf-kappab pathway in inflammation. Cold Spring Harb Perspect Biol. 2009; 1(6):001651.
62. Nakagawa S, Kim J-E, Lee R, Malberg JE, Chen J, Steffen C, et al.Regulation of neurogenesis in adult mouse hippocampus by camp and the camp response element-binding protein. J Neurosci. 2002; 22(9):3673-82.
63. Wen AY, Sakamoto KM, Miller LS. The role of the transcription factor creb in immune function. J Immunol. 2010; 185(11):6413-9.
64. Palumbo ML, Canzobre MC, Pascuan CG, Ríos H, Wald M, Genaro AM. Stress induced cognitive deficit is differentially modulated in balb/c and c57bl/6 mice: correlation with th1/th2 balance after stress exposure. J Neuroimmunol. 2010; 218(1-2):12-20.
65. Kaufmann I, Eisner C, Richter P, Huge V, Beyer A, Chouker A, et al.Lymphocyte subsets and the role of th1/th2 balance in stressed chronic pain patients. Neuroimmunomodulation. 2007; 14(5):272-80.
66. Schwarz MJ, Chiang S, Müller N, Ackenheil M. T-helper-1 and t-helper-2 responses in psychiatric disorders. Brain Behav Immun. 2001; 15(4):340-70.
67. Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, et al.Signal-induced site-specific phosphorylation targets i kappa b alpha to the ubiquitin-proteasome pathway. Genes Dev. 1995; 9(13):1586-97.
68. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. The ubiquitin-proteasome pathway is required for processing the nf-kappa b1 precursor protein and the activation of nf-kappa b. Cell. 1994; 78(5):773-85.
69. Chen ZJ. Ubiquitin signalling in the nf-kappab pathway. Nat Cell Biol. 2005; 7(8):758-65.
70. Ben-Neriah Y. Regulatory functions of ubiquitination in the immune system. Nat Immunol. 2002; 3(1):20-6.
71. Upadhya SC, Smith TK, Hegde AN. Ubiquitin-proteasome-mediated creb repressor degradation during induction of long-term facilitation. J Neurochem. 2004; 91(1):210-9.
72. Comerford KM, Leonard MO, Karhausen J, Carey R, Colgan SP, Taylor CT. Small ubiquitin-related modifier-1 modification mediates resolution of creb-dependent responses to hypoxia. Proc Natl Acad Sci U S A. 2003; 100(3):986-91.
73. Koo JW, Duman RS. Il-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci U S A. 2008; 105(2):751-6.
74. Koo JW, Russo SJ, Ferguson D, Nestler EJ, Duman RS. Nuclear factor-kappab is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci U S A. 2010; 107(6):2669-74.
75. Morgan CA3rd, Rasmusson AM, Wang S, Hoyt G, Hauger RL, Hazlett G. Neuropeptide-y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report. Biol Psychiatry. 2002; 52(2):136-42.
76. Russo SJ, Murrough JW, Han M-H, Charney DS, Nestler EJ. Neurobiology of resilience. Nat Neurosci. 2012; 15(11):1475-84.
77. Nestler EJ, Gould E, Manji H, Buncan M, Duman RS, Greshenfeld HK, et al.Preclinical models: status of basic research in depression. Biol Psychiatry. 2002; 52(6):503-28.
78. Willner P. Chronic mild stress (cms) revisited: consistency and behavioural-neurobiological concordance in the effects of cms. Neuropsychobiology. 2005; 52(2):90-110.